Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1420477-60-6
Purity
95%
Acalabrutinib is an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. It prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. It also plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.
Properties
Name
Acalabrutinib
Smiles
CC#CC(=O)N1CCC[C@H]1C2=NC(C=3C=CC(=CC3)C(=O)NC=4C=CC=CN4)=C5C(N)=NC=CN25
Targets
Please log in to see this information
Impurity
SDS
ACP-196 | acalabrutinib | calquence
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$47
2 mg
$49
5 mg
$50
10 mg
$51
15 mg
$52
20 mg
$53
25 mg
$59
30 mg
$65
35 mg
$73
40 mg
$80
45 mg
$87
50 mg
$94
75 mg
$100
100 mg
$POA
Quantity
1
Total amount
$ 50
ACP-196 | acalabrutinib | calquence
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.